Target intelligence / Profile preview

T cell receptor alpha variable 39 (TRAV39)

Target
TRAV39
Molecular classification
Receptor, Variable region gene segment, T cell receptor variable (TR V) gene
01

Overview

T cell receptor alpha variable 39 (TRAV39) encodes the V (variable) region of the alpha chain of the T cell receptor (TCR), a protein complex expressed on the surface of T lymphocytes that is essential for antigen recognition and initiating T cell-mediated adaptive immune responses[1][7]. TRAV39 is one of many variable (V) gene segments that participate in somatic recombination during T cell development, contributing to the diversity of the T cell receptor repertoire[1][2][4]. The alpha-beta TCR recognises peptide-MHC complexes presented by antigen-presenting cells, triggering intracellular signaling and T-cell responses[1][3][7]. The gene segment itself does not act as a direct therapeutic target; rather, it forms part of the TCR complex whose broad function is critical in immunity[1][3][7]. TRAV39 is a variable segment; it is not a full receptor on its own nor an independent drug target. No drugs are currently known to interact with this specific gene segment, and it is not used as a clinical biomarker or a therapeutic target. There are no unique safety concerns tied to TRAV39, as its role is as a genomic element involved in TCR gene rearrangement.

Other names
TCRAV27S1TCRAV39S1TRAV39T cell receptor alpha variable 39
02

Biological functions

Immune responseAntigen recognitionSignal transduction
03

Disease associations

Other (no direct implication in specific diseases as an isolated gene segment)

Beyond the preview

Go deeper on T cell receptor alpha variable 39 (TRAV39).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor alpha variable 39 (TRAV39).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call